產品分類
Phospholipids
PEG Derivatives
Block Copolymers
Gold Nanoparticles
Fe3O4 Magnetic nano
Fluorescent dyes
Protein Crosslinkers
Monodispersed PEGs
Click chemistry
Medicinal polymer
APIs cancer
Fluorescence quantum dot
MRI imaging
Microspheres
PROTAC技術
semiconductor
Synthetic chemistry
Nano drug delivery
Others
快速訂購
31952518
  • 029-86354885
  • 18392009562
Home > Products > APIs cancer> Hot APIs cancer> AP24534; AP-24534; AP 24534; Ponatinib HCl; Ponatinib hydrochloride,CAS1114544-31-8
AP24534; AP-24534; AP 24534; Ponatinib HCl; Ponatinib hydrochloride,CAS1114544-31-8
Catalog # Pkg Size Price Quantity Shopping Cart
R-SX-793 1 ￥ 1
加入購物車
結構式
外觀 N/A
分子量 569.02
溶解度 N/A
CAS號 1114544-31-8
質量控制 N/A
儲存條件 N/A
保存時間 N/A
其他信息 價格1，就是價格現詢
ponatinib, also known as AP24534 is an oral drug for the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome–positive (Ph+) acute lymphoblastic leukemia (ALL). It is a multi-targeted tyrosine-kinase inhibitor. Some forms of CML, those that have the T315I mutation, are resistant to current therapies such as imatinib. Ponatinib has been designed to be effective against these types of tumors. Ponatinib was approved in 2012.西安瑞禧生物提供各種抑制劑材料。
親，說點什么吧，您的評價對其它買家很有幫助哦~
“好評，中評，差評”請?zhí)顚懫湟慌秪
您的昵稱

合作品牌
?
庫存查詢